Clopidogrel and Retinopathy - a phase IV clinical study of FDA data

Summary:

Retinopathy is reported as a side effect among people who take Clopidogrel (clopidogrel), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Metformin, and have High blood pressure.

The phase IV clinical study analyzes which people have Retinopathy when taking Clopidogrel. It is created by eHealthMe based on reports of 91,038 people who have side effects when taking Clopidogrel from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Retinopathy?

Retinopathy (acute damage to the retina of the eye) is found to be associated with 440 drugs and 494 conditions by eHealthMe. Check the latest studies of Retinopathy.

On Jul, 11, 2026

91,038 people reported to have side effects when taking Clopidogrel.
Among them, 20 people (0.02%) have Retinopathy.

Among these 20 people:

How long have people been on Clopidogrel when they have Retinopathy? *

What is the gender of people who have Retinopathy when taking Clopidogrel? *

female: 27.78 %
male: 72.22 %

What is the age of people who have Retinopathy when taking Clopidogrel? *

What are other drugs people take besides Clopidogrel? *

What are other side effects people have besides Retinopathy? *

Blindness: 8 people, 40.00%
Optic Neuropathy (optic nerve damage): 6 people, 30.00%
Retinal Disorder (disease of retina): 4 people, 20.00%
Blood Glucose Decreased: 3 people, 15.00%
Visual Impairment: 3 people, 15.00%
Pain In Extremity: 3 people, 15.00%
Fall: 3 people, 15.00%
Toxic Optic Neuropathy (optic nerve damage caused by toxic (harmful) substances): 3 people, 15.00%
Drug Ineffective: 2 people, 10.00%
Memory Loss: 2 people, 10.00%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 30.00%
High Blood Cholesterol: 4 people, 20.00%
Type 2 Diabetes: 2 people, 10.00%
Diabetes: 2 people, 10.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 10.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 10.00%
Type 1 Diabetes: 2 people, 10.00%
Bacterial Infection: 1 person, 5.00%
Blood Pressure Abnormal: 1 person, 5.00%
Cardiac Disorder: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and have Retinopathy?

- Check whether Retinopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopidogrel:

Clopidogrel (92,160 reports)

Retinopathy treatments and more:

Retinopathy (4,577 reports)

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinopathy:

Retinopathy (440 drugs)

Browse all the conditions that are associated with Retinopathy:

Retinopathy (494 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel (the active ingredients of Clopidogrel) and Clopidogrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.